DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Ungar B, Kopylov U, Engel T. et al.
Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab.
Aliment Pharmacol Ther 2017;
45: 276-282
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.